HMGB1 Promotes Systemic Lupus Erythematosus by Enhancing Macrophage Inflammatory Response

Background/Purpose. HMGB1, which may act as a proinflammatory mediator, has been proposed to contribute to the pathogenesis of multiple chronic inflammatory and autoimmune diseases including systemic lupus erythematosus (SLE); however, the precise mechanism of HMGB1 in the pathogenic process of SLE...

Full description

Saved in:
Bibliographic Details
Main Authors: Mudan Lu, Shanshan Yu, Wei Xu, Bo Gao, Sidong Xiong
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2015/946748
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832555980988088320
author Mudan Lu
Shanshan Yu
Wei Xu
Bo Gao
Sidong Xiong
author_facet Mudan Lu
Shanshan Yu
Wei Xu
Bo Gao
Sidong Xiong
author_sort Mudan Lu
collection DOAJ
description Background/Purpose. HMGB1, which may act as a proinflammatory mediator, has been proposed to contribute to the pathogenesis of multiple chronic inflammatory and autoimmune diseases including systemic lupus erythematosus (SLE); however, the precise mechanism of HMGB1 in the pathogenic process of SLE remains obscure. Method. The expression of HMGB1 was measured by ELISA and western blot. The ELISA was also applied to detect proinflammatory cytokines levels. Furthermore, nephritic pathology was evaluated by H&E staining of renal tissues. Results. In this study, we found that HMGB1 levels were significantly increased and correlated with SLE disease activity in both clinical patients and murine model. Furthermore, gain- and loss-of-function analysis showed that HMGB1 exacerbated the severity of SLE. Of note, the HMGB1 levels were found to be associated with the levels of proinflammatory cytokines such as TNF-α and IL-6 in SLE patients. Further study demonstrated that increased HMGB1 expression deteriorated the severity of SLE via enhancing macrophage inflammatory response. Moreover, we found that receptor of advanced glycation end products played a critical role in HMGB1-mediated macrophage inflammatory response. Conclusion. These findings suggested that HMGB1 might be a risk factor for SLE, and manipulation of HMGB1 signaling might provide a therapeutic strategy for SLE.
format Article
id doaj-art-39acb1e9aff9451ea6335c081f47586e
institution Kabale University
issn 2314-8861
2314-7156
language English
publishDate 2015-01-01
publisher Wiley
record_format Article
series Journal of Immunology Research
spelling doaj-art-39acb1e9aff9451ea6335c081f47586e2025-02-03T05:46:35ZengWileyJournal of Immunology Research2314-88612314-71562015-01-01201510.1155/2015/946748946748HMGB1 Promotes Systemic Lupus Erythematosus by Enhancing Macrophage Inflammatory ResponseMudan Lu0Shanshan Yu1Wei Xu2Bo Gao3Sidong Xiong4Institute for Immunobiology and Department of Immunology, Shanghai Medical College, Fudan University, Shanghai 200032, ChinaInstitute for Immunobiology and Department of Immunology, Shanghai Medical College, Fudan University, Shanghai 200032, ChinaJiangsu Key Laboratory of Infection and Immunity, Institutes of Biology and Medical Sciences, Soochow University, Suzhou 215123, ChinaInstitute for Immunobiology and Department of Immunology, Shanghai Medical College, Fudan University, Shanghai 200032, ChinaInstitute for Immunobiology and Department of Immunology, Shanghai Medical College, Fudan University, Shanghai 200032, ChinaBackground/Purpose. HMGB1, which may act as a proinflammatory mediator, has been proposed to contribute to the pathogenesis of multiple chronic inflammatory and autoimmune diseases including systemic lupus erythematosus (SLE); however, the precise mechanism of HMGB1 in the pathogenic process of SLE remains obscure. Method. The expression of HMGB1 was measured by ELISA and western blot. The ELISA was also applied to detect proinflammatory cytokines levels. Furthermore, nephritic pathology was evaluated by H&E staining of renal tissues. Results. In this study, we found that HMGB1 levels were significantly increased and correlated with SLE disease activity in both clinical patients and murine model. Furthermore, gain- and loss-of-function analysis showed that HMGB1 exacerbated the severity of SLE. Of note, the HMGB1 levels were found to be associated with the levels of proinflammatory cytokines such as TNF-α and IL-6 in SLE patients. Further study demonstrated that increased HMGB1 expression deteriorated the severity of SLE via enhancing macrophage inflammatory response. Moreover, we found that receptor of advanced glycation end products played a critical role in HMGB1-mediated macrophage inflammatory response. Conclusion. These findings suggested that HMGB1 might be a risk factor for SLE, and manipulation of HMGB1 signaling might provide a therapeutic strategy for SLE.http://dx.doi.org/10.1155/2015/946748
spellingShingle Mudan Lu
Shanshan Yu
Wei Xu
Bo Gao
Sidong Xiong
HMGB1 Promotes Systemic Lupus Erythematosus by Enhancing Macrophage Inflammatory Response
Journal of Immunology Research
title HMGB1 Promotes Systemic Lupus Erythematosus by Enhancing Macrophage Inflammatory Response
title_full HMGB1 Promotes Systemic Lupus Erythematosus by Enhancing Macrophage Inflammatory Response
title_fullStr HMGB1 Promotes Systemic Lupus Erythematosus by Enhancing Macrophage Inflammatory Response
title_full_unstemmed HMGB1 Promotes Systemic Lupus Erythematosus by Enhancing Macrophage Inflammatory Response
title_short HMGB1 Promotes Systemic Lupus Erythematosus by Enhancing Macrophage Inflammatory Response
title_sort hmgb1 promotes systemic lupus erythematosus by enhancing macrophage inflammatory response
url http://dx.doi.org/10.1155/2015/946748
work_keys_str_mv AT mudanlu hmgb1promotessystemiclupuserythematosusbyenhancingmacrophageinflammatoryresponse
AT shanshanyu hmgb1promotessystemiclupuserythematosusbyenhancingmacrophageinflammatoryresponse
AT weixu hmgb1promotessystemiclupuserythematosusbyenhancingmacrophageinflammatoryresponse
AT bogao hmgb1promotessystemiclupuserythematosusbyenhancingmacrophageinflammatoryresponse
AT sidongxiong hmgb1promotessystemiclupuserythematosusbyenhancingmacrophageinflammatoryresponse